+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Molecular Quality Controls Market Size, Share & Industry Trends Analysis Report By Analyte Type, By Application, By Product, By End User, By Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 113 Pages
  • April 2022
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5600614
The Latin America, Middle East and Africa Molecular Quality Controls Market is expected to witness market growth of 9.5% CAGR during the forecast period (2022-2028).

Molecular quality control seeks to identify problems in molecular diagnostic products and report them to management, affecting the decision on whether or not to release the product. Quality control procedures for molecular testing have become increasingly popular in recent years, especially for infectious disease tests, where quality control materials are readily available, tests are declared clear by the FDA, published quality control guidelines are available, and the tests are quantitative with a limited number of analytes. For some multiplex tests, such as the cystic fibrosis test, quality controls are also provided.

According to WHO studies, 7% of the global population carries the genes for hemoglobin disorders like sickle cell disease and thalassemia. As a result of the rising occurrence of such inherited illnesses, the necessity for molecular quality controls is growing in the region. A key driver of the Molecular Quality Control industry is the government's initiatives to promote clinical research. Product launches and permissions are the most popular ways for businesses to grow their global footprints and product lines. The expansion of the molecular quality controls Market can be attributed to increase funding for genomics, lower sequencing costs, and the rising prevalence of genetic diseases.

The molecular quality controls Market in LAMEA will grow in the future due to an increase in the incidence of infectious diseases, government attention on quality control in the pharmaceutical industry, and important firms' focus on grabbing opportunities in emerging countries. The rise of the molecular control Market in the region is due to an increase in the number of QC molecular labs. The Middle East and Africa (MEA), are developing as well, and are projected to overcome the effects of the covid-19 in the upcoming years.

The Brazil Market dominated the LAMEA Molecular Quality Controls Market by Country 2021, and is expected to continue to be a dominant Market till 2028; thereby, achieving a Market value of $4.3 million by 2028. The Argentina Market is poised to grow at a CAGR of 10% during (2022-2028). Additionally, The UAE Market is expected to experience a CAGR of 9.2% during (2022-2028).

Based on Analyte Type, the Market is segmented into Single-analyte Controls and Multi-analyte Controls. Based on Application, the Market is segmented into Infectious Diseases Diagnostics, Oncology Testing, Genetic Testing, and Others. Based on Product, the Market is segmented into Independent Controls and Instrument-specific Controls (PCR, DNA Sequencing & NGS, and Others). Based on End User, the Market is segmented into Diagnostic Laboratories, Hospitals, IVD Manufacturers & CROs, Academic & Research Institutes, and Others. Based on countries, the Market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The Market research report covers the analysis of key stakeholders of the Market. Key companies profiled in the report include Grifols, S.A, Abbott Laboratories, Quidel Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Seegene, Inc., Randox Laboratories Limited, F. Hoffmann-La Roche Ltd., Bio-Techne Corporation, and Microbiologics, Inc.

Scope of the Study


Market Segments Covered in the Report:


By Analyte Type
  • Single-analyte Controls
  • Multi-analyte Controls
By Application
  • Infectious Diseases Diagnostics
  • Oncology Testing
  • Genetic Testing
  • Others
By Product
  • Independent Controls
  • Instrument-specific Controls
    • PCR
    • DNA Sequencing & NGS
    • Others
By End User
  • Diagnostic Laboratories
  • Hospitals
  • IVD Manufacturers & CROs
  • Academic & Research Institutes
  • Others

By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Grifols, S.A
  • Abbott Laboratories
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Seegene, Inc.
  • Randox Laboratories Limited
  • F. Hoffmann-La Roche Ltd.
  • Bio-Techne Corporation
  • Microbiologics, Inc.

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Molecular Quality Controls Market, by Analyte Type
1.4.2 LAMEA Molecular Quality Controls Market, by Application
1.4.3 LAMEA Molecular Quality Controls Market, by Product
1.4.4 LAMEA Molecular Quality Controls Market, by End User
1.4.5 LAMEA Molecular Quality Controls Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Molecular Quality Controls Market
Chapter 4. LAMEA Molecular Quality Controls Market by Analyte Type
4.1 LAMEA Single-analyte Controls Market by Country
4.2 LAMEA Multi-analyte Controls Market by Country
Chapter 5. LAMEA Molecular Quality Controls Market by Application
5.1 LAMEA Infectious Diseases Diagnostics Market by Country
5.2 LAMEA Oncology Testing Market by Country
5.3 LAMEA Genetic Testing Market by Country
5.4 LAMEA Other Application Market by Country
Chapter 6. LAMEA Molecular Quality Controls Market by Product
6.1 LAMEA Independent Controls Market by Country
6.2 LAMEA Instrument-specific Controls Market by Country
6.3 LAMEA Molecular Quality Controls Market by Instrument-specific Controls Type
6.3.1 LAMEA PCR Market by Country
6.3.2 LAMEA DNA Sequencing & NGS Market by Country
6.3.3 LAMEA Others Market by Country
Chapter 7. LAMEA Molecular Quality Controls Market by End User
7.1 LAMEA Diagnostic Laboratories Market by Country
7.2 LAMEA Hospitals Market by Country
7.3 LAMEA IVD Manufacturers & CROs Market by Country
7.4 LAMEA Academic & Research Institutes Market by Country
7.5 LAMEA Others Market by Country
Chapter 8. LAMEA Molecular Quality Controls Market by Country
8.1 Brazil Molecular Quality Controls Market
8.1.1 Brazil Molecular Quality Controls Market by Analyte Type
8.1.2 Brazil Molecular Quality Controls Market by Application
8.1.3 Brazil Molecular Quality Controls Market by Product
8.1.3.1 Brazil Molecular Quality Controls Market by Instrument-specific Controls Type
8.1.4 Brazil Molecular Quality Controls Market by End User
8.2 Argentina Molecular Quality Controls Market
8.2.1 Argentina Molecular Quality Controls Market by Analyte Type
8.2.2 Argentina Molecular Quality Controls Market by Application
8.2.3 Argentina Molecular Quality Controls Market by Product
8.2.3.1 Argentina Molecular Quality Controls Market by Instrument-specific Controls Type
8.2.4 Argentina Molecular Quality Controls Market by End User
8.3 UAE Molecular Quality Controls Market
8.3.1 UAE Molecular Quality Controls Market by Analyte Type
8.3.2 UAE Molecular Quality Controls Market by Application
8.3.3 UAE Molecular Quality Controls Market by Product
8.3.3.1 UAE Molecular Quality Controls Market by Instrument-specific Controls Type
8.3.4 UAE Molecular Quality Controls Market by End User
8.4 Saudi Arabia Molecular Quality Controls Market
8.4.1 Saudi Arabia Molecular Quality Controls Market by Analyte Type
8.4.2 Saudi Arabia Molecular Quality Controls Market by Application
8.4.3 Saudi Arabia Molecular Quality Controls Market by Product
8.4.3.1 Saudi Arabia Molecular Quality Controls Market by Instrument-specific Controls Type
8.4.4 Saudi Arabia Molecular Quality Controls Market by End User
8.5 South Africa Molecular Quality Controls Market
8.5.1 South Africa Molecular Quality Controls Market by Analyte Type
8.5.2 South Africa Molecular Quality Controls Market by Application
8.5.3 South Africa Molecular Quality Controls Market by Product
8.5.3.1 South Africa Molecular Quality Controls Market by Instrument-specific Controls Type
8.5.4 South Africa Molecular Quality Controls Market by End User
8.6 Nigeria Molecular Quality Controls Market
8.6.1 Nigeria Molecular Quality Controls Market by Analyte Type
8.6.2 Nigeria Molecular Quality Controls Market by Application
8.6.3 Nigeria Molecular Quality Controls Market by Product
8.6.3.1 Nigeria Molecular Quality Controls Market by Instrument-specific Controls Type
8.6.4 Nigeria Molecular Quality Controls Market by End User
8.7 Rest of LAMEA Molecular Quality Controls Market
8.7.1 Rest of LAMEA Molecular Quality Controls Market by Analyte Type
8.7.2 Rest of LAMEA Molecular Quality Controls Market by Application
8.7.3 Rest of LAMEA Molecular Quality Controls Market by Product
8.7.3.1 Rest of LAMEA Molecular Quality Controls Market by Instrument-specific Controls Type
8.7.4 Rest of LAMEA Molecular Quality Controls Market by End User
Chapter 9. Company Profiles
9.1 Grifols, S.A
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Approvals:
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Quidel Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.6 SWOT Analysis
9.5 Bio-Rad laboratories, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Seegene, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Research & Development Expense
9.7 Randox Laboratories Limited
9.7.1 Company Overview
9.8 F. Hoffmann-La Roche Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.9 Bio-Techne Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.10. Microbiologics, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:

Companies Mentioned

  • Grifols, S.A
  • Abbott Laboratories
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Seegene, Inc.
  • Randox Laboratories Limited
  • F. Hoffmann-La Roche Ltd.
  • Bio-Techne Corporation
  • Microbiologics, Inc.

Methodology

Loading
LOADING...